Pharmaceuticals in China
Pharmaceuticals in China
SUMMARY
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Chinese pharmaceuticals market had total revenues of $142,557.2m in 2019, representing a compound annual growth rate (CAGR) of 8% between 2015 and 2019.
- The healthcare sector, particularly biopharmaceuticals, has been identified as an area of priority for the Chinese government.
- On the whole, China’s pharmaceutical market is slowly opening up, shunning protectionism and projecting an image of efficiency, transparency, and opportunity.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts
- What was the size of the China pharmaceuticals market by value in 2019?
- What will be the size of the China pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the China pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in China's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do leading players face?
8 COMPANY PROFILES
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Guangzhou Pharmaceuticals Corp
8.4. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do leading players face?
8 COMPANY PROFILES
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Guangzhou Pharmaceuticals Corp
8.4. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: China pharmaceuticals market value: $ billion, 2015-19
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: China pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: China pharmaceuticals market share: % share, by value, 2019
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Guangzhou Pharmaceuticals Corp: key facts
Table 11: Guangzhou Pharmaceuticals Corp: Key Employees
Table 12: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 13: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 14: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios (Continued)
Table 15: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 16: China size of population (million), 2015-19
Table 17: China gdp (constant 2005 prices, $ billion), 2015-19
Table 18: China gdp (current prices, $ billion), 2015-19
Table 19: China inflation, 2015-19
Table 20: China consumer price index (absolute), 2015-19
Table 21: China exchange rate, 2015-19
Table 1: China pharmaceuticals market value: $ billion, 2015-19
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: China pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: China pharmaceuticals market share: % share, by value, 2019
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Guangzhou Pharmaceuticals Corp: key facts
Table 11: Guangzhou Pharmaceuticals Corp: Key Employees
Table 12: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 13: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 14: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios (Continued)
Table 15: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 16: China size of population (million), 2015-19
Table 17: China gdp (constant 2005 prices, $ billion), 2015-19
Table 18: China gdp (current prices, $ billion), 2015-19
Table 19: China inflation, 2015-19
Table 20: China consumer price index (absolute), 2015-19
Table 21: China exchange rate, 2015-19
LIST OF FIGURES
Figure 1: China pharmaceuticals market value: $ billion, 2015-19
Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: China pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in China, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in China, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in China, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in China, 2019
Figure 10: China pharmaceuticals market share: % share, by value, 2019
Figure 1: China pharmaceuticals market value: $ billion, 2015-19
Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: China pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in China, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in China, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in China, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in China, 2019
Figure 10: China pharmaceuticals market share: % share, by value, 2019
